Colorectal Cancer and Genetic Alterations in the Wnt Pathway

Total Page:16

File Type:pdf, Size:1020Kb

Colorectal Cancer and Genetic Alterations in the Wnt Pathway Oncogene (2006) 25, 7531–7537 & 2006 Nature Publishing Group All rights reserved 0950-9232/06 $30.00 www.nature.com/onc REVIEW Colorectal cancer and genetic alterations in the Wnt pathway S Segditsas and I Tomlinson Molecular and Population Genetics Laboratory, London Research Institute, Cancer Research UK, London, UK In colorectal tumours, Wnt pathway genetics continues to other Wnt pathway components in benign and malig- be dominated by mutations in the adenomatous polyposis nant colorectal tumours. The functional consequences coli (APC) gene. Germline mutations cause familial of these changes are mentioned briefly, but many are adenomatous polyposis and at least two-thirds of sporadic covered more comprehensively by other papers in this colorectal tumours also acquire APC mutations, quite volume. In order to minimize repetition in this issue, we possibly as the initiating events in tumorigenesis. These have not included a figure outlining the Wnt pathway. mutations almost always cause loss of the C-terminal Please refer to other papers if needed. functions of the APC protein – probably involved in microtubule binding, cell polarity and chromosome segregation – and deletion of the SAMP repeats that are important for binding to axin and formation of the APC mutation spectrum beta-catenin phosphorylation complex. The truncated APC APC proteins are, in general, stable and almost certainly Although germline mutations only account for 1% retain some activity in beta-catenin binding. The ‘two hits’ of all colorectal cancer cases, they almost invariably at APC are coselected so as to produce an optimal cause a FAP phenotype. This condition is typified by activation of Wnt signalling (just-right hypothesis). In a hundreds or thousands of colorectal adenomas, one or minority of colorectal tumours, Wnt activation can occur more of which usually progresses to carcinoma by the through mutations that affect phosphorylation sites within fourth decade if the patient is untreated (Galiatsatos and exon 3 of beta-catenin, causing protein stabilization. In Foulkes, 2006). The great majority of FAP-associated APC other tumours, epigenetic transcriptional silencing or mutations lead to a truncated protein. Frameshift mutation of the secreted frizzled-related proteins may mutations outnumber nonsense changes by about two- modulate Wnt levels. Mutations in the Wnt components to-one, and the most common nonsense changes are AXIN1, AXIN2 and TCF4 have been found in micro- C>T mutations, probably resulting from spontaneous et al satellite-unstable colon cancers, but it is not clear in every deamination of 5-methylcytosine (Laurent-Puig ., case whether these changes are functional. Therapeutic 1998). In addition to protein-truncating mutations, modulation of the Wnt pathway remains an attractive deletions of the whole gene or exon(s) have been et al therapeutic possibility for colorectal carcinomas. reported in about 5% of FAP cases (Sieber ., 2002). Oncogene (2006) 25, 7531–7537. doi:10.1038/sj.onc.1210059 The protein-truncating mutations can occur anywhere in the APC gene, but the classical phenotype of more Keywords: APC; beta-catenin; ‘just right’ than 100 adenomas is associated with mutations between codons 178 and 309 and between codons 409 and 1580, corresponding to exons 5–8, 9–14 and the first half of the large final exon 15 (Fearnhead et al., 2001). Frameshift mutations at codons 1061 and 1309 are Introduction particularly common in western European populations; both of these regions contain short repeats, and a degree It is over 15 years since the adenomatous polyposis coli of hypermutation, plus genetic drift, probably accounts (APC) gene was found to be mutated in familial for their relatively high frequency. From the persepec- adenomatous polyposis (FAP) and, subsequently, in a tive of APC mutations, the most important functional very high proportion of sporadic colorectal tumours. Of domains of the APC gene appear to be the first serine course, the connection with the Wnt pathway was not alanine methionine proline (SAMP) (axin binding) known at that time, but it is arguable that without the repeat at codon 1580 (Smits et al., 1999) and the first, cloning of APC, this issue of Oncogene would not exist. second and third 20-amino acid repeats (20AARs) In this paper, we shall focus on the genetic and involved in beta-catenin binding and degradation. The epigenetic changes that occur in APC, beta-catenin and great majority of pathogenic APC mutations truncate the protein before the first SAMP repeat and leave a stable, truncated protein that encodes 0–3 20AARs Correspondence: Professor I Tomlinson, Molecular and Population Genetics Laboratory, London Research Institute, Cancer Research (Figure 1). UK, 44, Lincoln’s Inn Fields, London WC2A3PX, UK. In colorectal tumours from FAP patients, the E-mail: [email protected] germline wild-type allele either undergoes loss of Colorectal cancer and genetic alterations in the Wnt pathway S Segditsas and I Tomlinson 7532 Heptad repeats 15aa repeats SAMP repeats Basic domain (dimerisation) (β-catenin binding) (axin binding) (microtubule binding) 6 57 453 767 1020 1169 1266 1495 2033 2200 2400 2560 2843 1379 1581 Armadillo repeats 20aa repeats EB1 and HDLG (β-catening binding/degradation) binding sites a Gl mut allele Gl wt allele b Gl mut allele Gl wt allele c Gl mut allele Gl wt allele Figure 1 The ‘just-right’ model. The figure shows the multiple domains of the APC protein and the correlation between the position of the germline (gl) mutation and that of the somatic mutation. (a) Germline mutations between the first and the second 20AAR are associated with LOH. (b) Germline mutations before the first 20AAR are associated with somatic mutations between the second and third 20AAR. (c) Germline mutations after the second 20AAR are associated with somatic mutations before the first 20AAR. heterozygosity (LOH) or acquires a protein-truncating one-third to one-half of tumours, a frequency lower mutation. In general, these are thought to be sponta- than that at many other bona fide tumour suppressor neous events and APC is often cited as a classical loci. tumour-suppressor gene, both alleles of which must be The reason for the MCR and relatively low frequency inactivated for tumorigenesis to begin. It has been of LOH at APC came from studies of FAP (Lamlum argued, however, that the number of adenomas in the et al., 1999). It was found that LOH is strongly FAP colon is too great for each one to have acquired a associated with germline mutations between the first ‘second hit’, especially if FAP adenomas are frequently and second 20AAR (codons 1285–1379). Germline polyclonal. The validity of such calculations is inhe- mutations before codon 1280 are associated with rently difficult to confirm or refute, since they depend on somatic mutations between the second and third the one hand on estimations of the susceptible cell 20AAR (codons 1400 and 1495); and germline muta- population and, on the other, on finding ‘second hits’ in tions after codon 1400 are associated with somatic almost all early tumours, a technically very demanding mutations before codon 1280 (Lamlum et al., 1999; task. For the purposes of this paper, it will be assumed Albuquerque et al., 2002; Crabtree et al., 2003) that FAP adenomas do have (at least) two hits, although (Figure 1). Most tumours end up with APC alleles that the possibility that very early lesions can grow without a encode a total of two 20AARs. Similar associations exist somatic APC mutation must be borne in mind. for sporadic colorectal cancers. This association has The somatic mutations that occur in sporadic colo- been proposed to cause an optimal level of Wnt rectal tumours are similar in spectrum and location to signalling/beta-catenin activation (Lamlum et al., 1999; the somatic mutations in FAP polyps. Albuquerque et al., 2002). Whether this level is the maximum level is unclear, since APC protein truncated at codon 1309 has been shown to have increased Selective constraints on APC mutations in inherited and stability compared with other mutants (Dihlmann sporadic tumours et al., 1999) and many truncated APC proteins retain some ability to bind and, perhaps, degrade beta-catenin In recent years, it has become established that the (Rubinfeld et al., 1997). Absence of APC appears to be somatic APC mutation in FAP tumours – and sporadic selectively disadvantageous (Schneikert and Behrens, colorectal carcinomas – is not simply an event that 2006). Whatever the case, it is clear that selective removes function of the protein encoded by the germline constraints act on colorectal tumours such that some wild-type allele. It had been known for some years that combinations of APC mutations provide a superior somatic APC mutations tend to occur in a restricted growth advantage for the tumour cell. region of the gene (mutation cluster region (MCR)) that The ‘1st hit-2nd hit’ association at APC has been lay approximately between codons 1250 and 1450 dubbed the ‘just right’ hypothesis (Albuquerque et al., (Miyoshi et al., 1992). LOH occurred in about 2002). This is a convenient term that encapsulates the Oncogene Colorectal cancer and genetic alterations in the Wnt pathway S Segditsas and I Tomlinson 7533 notion well – and it will be used below – although we did (i) Loss of germline wt + truncating mutation not use such a term originally, because the selective constraints are evidently not so rigid that deviation from the total of two 20AARs cannot be tolerated in a Phenotype substantial minority of lesions (Lamlum et al., 1999; Crabtree et al., 2003). Further studies have shown that a LOH as first somatic event the ‘just right’ model applies to extracolonic lesions in FAP, but that the combination of mutations is different X (Lamlum et al., 1999; Groves et al., 2002). In desmoids LOH Allelotype + + or and uppergastrointestinal tumours, LOH is associated with germline APC mutations between the second and third 20AARs, and the optimum mutant proteins X appear to encode a total of three or four 20AARs.
Recommended publications
  • Original Article Association of AXIN2 and MMP7 Polymorphisms with Non-Small Cell Lung Cancer in Chinese Han Population
    Int J Clin Exp Pathol 2016;9(2):2253-2258 www.ijcep.com /ISSN:1936-2625/IJCEP0009888 Original Article Association of AXIN2 and MMP7 polymorphisms with non-small cell lung cancer in Chinese Han population Shuguang Han, Lei Lv, Xinhua Wang, Xun Wang, Hongqing Zhao Department of Respiratory Medicine, Second People’s Hospital of Wuxi, Wuxi, Jiangsu, China Received May 4, 2015; Accepted June 23, 2015; Epub February 1, 2016; Published February 15, 2016 Abstract: Objectives: This study aimed to explore the effect of AXIN2 and MMP7 polymorphisms on non-small cell lung cancer (NSCLC) susceptibility; in addition, the interaction between gene polymorphisms and environment was also displayed. Methods: The genotyping was conducted by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) in 102 patients with NSCLC and 120 healthy controls. Odds ratio (OR) and 95% con- fidence interval (CI) were calculated to assess the relevance strength of AXIN2 and MMP7 polymorphisms with NSCLC. The x² test was used to compare to the frequencies difference of genotypes and alleles in cases and controls and Hardy-Weinberg equilibrium (HWE) test. The haplotype and interaction analyses were performed by haploview and MDR software, respectively. Results: The genotype frequencies of all polymorphisms in the control group conformed to HWE. GG genotype frequency of AXIN2 rs2240307 polymorphism was significantly higher in cases than controls (P=0.041). Similarly, rs2240308 in AXIN2 gene was also increased the susceptibility to NSCLC remarkably (OR=2.412, 95% CI=1.025-5.674). What’s more, haplotype A-G-G in AXIN2 might play a protective role in NSCLC (OR=0.462, 95% CI=0.270-0.790).
    [Show full text]
  • APC Mutations As a Potential Biomarker for Sensitivity To
    Published OnlineFirst February 8, 2017; DOI: 10.1158/1535-7163.MCT-16-0578 Companion Diagnostics and Cancer Biomarkers Molecular Cancer Therapeutics APC Mutations as a Potential Biomarker for Sensitivity to Tankyrase Inhibitors in Colorectal Cancer Noritaka Tanaka1,2, Tetsuo Mashima1, Anna Mizutani1, Ayana Sato1,3, Aki Aoyama3,4, Bo Gong3,4, Haruka Yoshida1, Yukiko Muramatsu1, Kento Nakata1,5, Masaaki Matsuura6, Ryohei Katayama4, Satoshi Nagayama7, Naoya Fujita3,4,5, Yoshikazu Sugimoto2, and Hiroyuki Seimiya1,3,5 Abstract In most colorectal cancers, Wnt/b-catenin signaling is acti- "short" truncated APCs lacking all seven b-catenin-binding vated by loss-of-function mutations in the adenomatous polyposis 20-amino acid repeats (20-AARs). In contrast, the drug-resistant coli (APC) gene and plays a critical role in tumorigenesis. cells possessed "long" APC retaining two or more 20-AARs. Knock- Tankyrases poly(ADP-ribosyl)ate and destabilize Axins, a neg- down of the long APCs with two 20-AARs increased b-catenin, ative regulator of b-catenin, and upregulate b-catenin signaling. Tcf/LEF transcriptional activity and its target gene AXIN2 expres- Tankyrase inhibitors downregulate b-catenin and are expected sion. Under these conditions, tankyrase inhibitors were able to to be promising therapeutics for colorectal cancer. However, downregulate b-catenin in the resistant cells. These results indicate colorectal cancer cells are not always sensitive to tankyrase that the long APCs are hypomorphic mutants, whereas they exert inhibitors, and predictive biomarkers for the drug sensitivity a dominant-negative effect on Axin-dependent b-catenin degra- remain elusive. Here we demonstrate that the short-form APC dation caused by tankyrase inhibitors.
    [Show full text]
  • Β-Catenin-Mediated Wnt Signal Transduction Proceeds Through an Endocytosis-Independent Mechanism
    bioRxiv preprint doi: https://doi.org/10.1101/2020.02.13.948380; this version posted February 20, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. β-catenin-Mediated Wnt Signal Transduction Proceeds Through an Endocytosis-Independent Mechanism Ellen Youngsoo Rim1, , Leigh Katherine Kinney1, and Roel Nusse1, 1Howard Hughes Medical Institute, Department of Developmental Biology, Stanford University School of Medicine, Stanford, CA 94305, USA The Wnt pathway is a key intercellular signaling cascade that by GSK3β is inhibited. This leads to β-catenin accumulation regulates development, tissue homeostasis, and regeneration. in the cytoplasm and concomitant translocation into the nu- However, gaps remain in our understanding of the molecular cleus, where it can induce transcription of target genes. The events that take place between ligand-receptor binding and tar- importance of β-catenin stabilization in Wnt signal transduc- get gene transcription. Here we used a novel tool for quanti- tion has been demonstrated in many in vivo and in vitro con- tative, real-time assessment of endogenous pathway activation, texts (8, 9). However, immediate molecular responses to the measured in single cells, to answer an unresolved question in the ligand-receptor interaction and how they elicit accumulation field – whether receptor endocytosis is required for Wnt signal transduction. We combined knockdown or knockout of essential of β-catenin are not fully elucidated. components of Clathrin-mediated endocytosis with quantitative One point of uncertainty is whether receptor endocyto- assessment of Wnt signal transduction in mouse embryonic stem sis following Wnt binding is required for signal transduc- cells (mESCs).
    [Show full text]
  • Discovery of a Novel Triazolopyridine Derivative As a Tankyrase Inhibitor
    International Journal of Molecular Sciences Article Discovery of a Novel Triazolopyridine Derivative as a Tankyrase Inhibitor Hwani Ryu 1, Ky-Youb Nam 2, Hyo Jeong Kim 1, Jie-Young Song 1 , Sang-Gu Hwang 1 , Jae Sung Kim 1 , Joon Kim 3,* and Jiyeon Ahn 1,* 1 Division of Radiation Biomedical Research, Korea Institute of Radiological & Medical Sciences, Seoul 01812, Korea; [email protected] (H.R.); [email protected] (H.J.K.); [email protected] (J.-Y.S.); [email protected] (S.-G.H.); [email protected] (J.S.K.) 2 Department of Research Center, Pharos I&BT Co., Ltd., Anyang 14059, Korea; [email protected] 3 Laboratory of Biochemistry, Division of Life Sciences, Korea University, Seoul 02841, Korea * Correspondence: [email protected] (J.K.); [email protected] (J.A.); Tel.: +82-2-970-1311 (J.A.) Abstract: More than 80% of colorectal cancer patients have adenomatous polyposis coli (APC) mutations, which induce abnormal WNT/β-catenin activation. Tankyrase (TNKS) mediates the release of active β-catenin, which occurs regardless of the ligand that translocates into the nucleus by AXIN degradation via the ubiquitin-proteasome pathway. Therefore, TNKS inhibition has emerged as an attractive strategy for cancer therapy. In this study, we identified pyridine derivatives by evaluating in vitro TNKS enzyme activity and investigated N-([1,2,4]triazolo[4,3-a]pyridin-3-yl)-1-(2- cyanophenyl)piperidine-4-carboxamide (TI-12403) as a novel TNKS inhibitor. TI-12403 stabilized β β AXIN2, reduced active -catenin, and downregulated -catenin target genes in COLO320DM and DLD-1 cells.
    [Show full text]
  • Mutational Analysis of AXIN2, MSX1, and PAX9 in Two Mexican Oligodontia Families
    Mutational analysis of AXIN2, MSX1, and PAX9 in two Mexican oligodontia families Y.D. Mu1,2, Z. Xu1, C.I. Contreras1, J.S. McDaniel1, K.J. Donly1 and S. Chen1 1Department of Developmental Dentistry, Dental School, University of Texas Health Science Center, San Antonio, Texas, USA 2Stomotology Department, Sichuan Provincial People’s Hospital, Chengdu, Sichuan, China Corresponding author: S. Chen E-mail: [email protected] Genet. Mol. Res. 12 (4): 4446-4458 (2013) Received July 4, 2012 Accepted May 15, 2013 Published October 10, 2013 DOI http://dx.doi.org/10.4238/2013.October.10.10 ABSTRACT. The genes for axin inhibition protein 2 (AXIN2), msh homeobox 1 (MSX1), and paired box gene 9 (PAX9) are involved in tooth root formation and tooth development. Mutations of the AXIN2, MSX1, and PAX9 genes are associated with non-syndromic oligodontia. In this study, we investigated phenotype and AXIN2, MSX1, and PAX9 gene variations in two Mexican families with non-syndromic oligodontia. Individuals from two families underwent clinical examinations, including an intra-oral examination and panoramic radiograph. Retrospective data were reviewed, and peripheral blood samples were collected. The exons and exon-intronic boundaries of the AXIN2, MSX1, and PAX9 genes were sequenced and analyzed. Protein and messenger RNA structures were predicted using bioinformative software programs. Clinical and oral examinations revealed isolated non-syndromic oligodontia in the two Mexican families. The average number of missing teeth was 12. The sequence analysis of exons and exon-intronic regions of AXIN2, MSX1, and PAX9 revealed 11 single- nucleotide polymorphisms (SNPs), including seven in AXIN2, two Genetics and Molecular Research 12 (4): 4446-4458 (2013) ©FUNPEC-RP www.funpecrp.com.br AXIN2, MSX1, and PAX9 SNPs and oligodontia 4447 in MSX1, and three in PAX9.
    [Show full text]
  • Novel Missense Mutations in the AXIN2 Gene Associated with Non
    a r c h i v e s o f o r a l b i o l o g y 5 9 ( 2 0 1 4 ) 3 4 9 – 3 5 3 Available online at www.sciencedirect.com ScienceDirect journal homepage: http://www.elsevier.com/locate/aob Novel missense mutations in the AXIN2 gene associated with non-syndromic oligodontia a,1 a,1 b a Singwai Wong , Haochen Liu , Baojing Bai , Huaiguang Chang , c,d e a, a, Hongshan Zhao , Yixiang Wang , Dong Han **, Hailan Feng * a Department of Prosthodontics, Peking University School and Hospital of Stomatology, Beijing, China b Department of Prosthodontics, Beijing Stomatology Hospital, Beijing, China c Department of Medical Genetics, Peking University Health Science Center, Beijing, China d Peking University Center for Human Disease Genomics, Peking University Health Science Center, Beijing, China e Central Laboratory, Peking University School and Hospital of Stomatology, Beijing, China a r t i c l e i n f o a b s t r a c t Article history: Objective: Oligodontia, which is the congenital absence of six or more permanent teeth Accepted 23 December 2013 excluding third molars, may contribute to masticatory dysfunction, speech alteration, aesthetic problems and malocclusion. To date, mutations in EDA, AXIN2, MSX1, PAX9, Keywords: WNT10A, EDAR, EDARADD, NEMO and KRT 17 are known to associate with non-syndromic oligodontia. The aim of the study was to search for AXIN2 mutations in 96 patients with non- Non-syndromic oligodontia syndromic oligodontia. Mutation screening AXIN2 Design: We performed mutation analysis of 10 exons of the AXIN2 gene in 96 patients with isolated non-syndromic oligodontia.
    [Show full text]
  • Hypodontia As a Risk Marker for Epithelial Ovarian Cancer a Case-Controlled Study
    RESEARCH Hypodontia as a risk marker for epithelial ovarian cancer A case-controlled study Leigh A. Chalothorn, DMD, MS; Cynthia S. Beeman, DDS, PhD; Jeffrey L. Ebersole, PhD; G. Thomas Kluemper, DMD, MS; E. Preston Hicks, DDS, MS, MSD; Richard J. Kryscio, PhD; Christopher P. DeSimone, MD; Susan C. Modesitt, MD ecent advances in genetic research have allowed for A D A a greater understanding ABSTRACT J 2 2 of the underlying causes C N of human disease, fur- Background. Genetic mutations that result in O O N I thering the exploration and insight hypodontia also may be associated with abnormali- T T R I A N U C into possible genetic associations ties in other parts of the body. The authors conducted I U A N G E D among seemingly unrelated condi- a study to establish the prevalence rates of hypodontia R 2 TI E tions. More than 300 genes are among subjects with epithelial ovarian cancer (EOC) and CL involved in odontogenesis, and control subjects to explore possible genetic associations between these mutations in several of these genes two phenotypes. have been linked with hypodontia.1,2 Methods. The authors recruited 50 subjects with EOC and 100 control The genes that control the develop- subjects who did not have EOC. The authors performed a dental exami- ment of teeth also have important nation on each subject to detect hypodontia, and they reviewed pertinent functions in other organs and body radiographs and dental histories. They also recorded any family history systems. Therefore, it is plausible to of cancer and hypodontia.
    [Show full text]
  • Wnt/Β-Catenin Signaling Via Axin2 Is Required for Myogenesis And
    © 2016. Published by The Company of Biologists Ltd | Development (2016) 143, 3128-3142 doi:10.1242/dev.139907 RESEARCH ARTICLE Wnt/β-catenin signaling via Axin2 is required for myogenesis and, together with YAP/Taz and Tead1, active in IIa/IIx muscle fibers Danyil Huraskin1,‡, Nane Eiber1,‡, Martin Reichel2,*, Laura M. Zidek3, Bojana Kravic1, Dominic Bernkopf2, Julia von Maltzahn3,Jürgen Behrens2 and Said Hashemolhosseini1,¶ ABSTRACT are expressed in the dorsal ectoderm, and Wnt11 is expressed in the Canonical Wnt/β-catenin signaling plays an important role in epaxial dermomyotome. In adult muscle, Wnt proteins are expressed myogenic differentiation, but its physiological role in muscle fibers upon regeneration (Polesskaya et al., 2003; von Maltzahn et al., remains elusive. Here, we studied activation of Wnt/β-catenin 2012). Non-canonical Wnt signaling through Wnt7a regulates signaling in adult muscle fibers and muscle stem cells in an Axin2 satellite cell number and the size of skeletal muscle (Le Grand et al., reporter mouse. Axin2 is a negative regulator and a target of Wnt/β- 2009; von Maltzahn et al., 2013). Generally, non-canonical Wnt catenin signaling. In adult muscle fibers, Wnt/β-catenin signaling is signaling is required for skeletal muscle development, while only detectable in a subset of fast fibers that have a significantly canonical Wnt signaling, especially via Wnt3a, has been smaller diameter than other fast fibers. In the same fibers, demonstrated to lead to increased fibrosis (Brack et al., 2007). immunofluorescence staining for YAP/Taz and Tead1 was In canonical Wnt signaling the Wnt binds to the Fzd and Lrp5/6 detected.
    [Show full text]
  • Association of Genetic Variation in Genes Implicated in the B-Catenin Destruction Complex with Risk of Breast Cancer
    2101 Association of Genetic Variation in Genes Implicated in the B-Catenin Destruction Complex with Risk of Breast Cancer Xianshu Wang,1 Ellen L. Goode,2 Zachary S. Fredericksen,2 Robert A. Vierkant,2 V. Shane Pankratz,2 Wen Liu-Mares,2 David N. Rider,2 Celine M. Vachon,2 James R. Cerhan,2 Janet E. Olson,2 and Fergus J. Couch1 Departments of 1Laboratory Medicine and Pathology and 2Health Sciences Research, Mayo Clinic, Rochester, Minnesota Abstract B P Aberrant Wnt/ -catenin signaling leading to nuclear 95% confidence intervals, 1.05-1.43; trend = 0.01). In accumulation of the oncogene product B-catenin is ob- addition, five SNPs in AXIN2 were associated with in- P served in a wide spectrum of human malignancies. creased risk of breast cancer ( trend < 0.05). Haplotype- The destruction complex in the Wnt/B-catenin pathway based tests identified significant associations between is critical for regulating the level of B-catenin in the specific haplotypes in APC and AXIN2 (P V 0.03) and cytoplasm and in the nucleus. Here, we report a com- breast cancer risk. Further characterization of the APC prehensive study of the contribution of genetic varia- and AXIN2 variants suggested that AXIN2 rs4791171 tion in six genes encoding the B-catenin destruction was significantly associated with risk in premeno- APC, AXIN1, AXIN2, CSNK1D, CSNK1E P complex ( , and pausal ( trend = 0.0002) but not in postmenopausal GSK3B) to breast cancer using a Mayo Clinic Breast women. The combination of our findings and numer- Cancer Case-Control Study. A total of 79 candidate ous genetic and functional studies showing that APC functional and tagging single nucleotide polymor- and AXIN2 perform crucial tumor suppressor func- phisms (SNP) were genotyped in 798 invasive cases tions suggest that further investigation of the contri- and 843 unaffected controls.
    [Show full text]
  • AXIN2 ) Polymorphisms May Be a Risk Factor for Selective Tooth Agenesis
    J Hum Genet (2006) 51:262–266 DOI 10.1007/s10038-005-0353-6 SHORT COMMUNICATION Adrianna Mostowska Æ Barbara Biedziak Pawel P. Jagodzinski Axis inhibition protein 2 (AXIN2 ) polymorphisms may be a risk factor for selective tooth agenesis Received: 24 October 2005 / Accepted: 21 November 2005 / Published online: 24 January 2006 Ó The Japan Society of Human Genetics and Springer-Verlag 2006 Abstract Selective tooth agenesis is the most common Introduction developmental abnormality of the human dentition. To date, this abnormality has been associated only with Hypodontia, defined as the congenital lack of one or mutations in MSX1 and PAX9 mutations, however it more permanent teeth, is the most common dental has recently been suggested that mutations of axis abnormality found in humans and affects approximately inhibition protein 2 (AXIN2) may also contribute to this 20% of the population worldwide (Vastardis 2000). The complex anomaly. The protein product of this gene is a etiology of this anomaly is very complex and is associ- negative regulator of the Wnt-signaling pathway. We ated with both genetic and environmental factors searched for AXIN2 variants in a group of patients with (Mostowska et al. 2003). Molecular studies of mice tooth agenesis who did not have mutations of MSX1 odontogenesis have shown that more than 200 genes are and PAX9. Using multi-temperature single-stranded involved in tooth development (Thesleff and Nieminen conformational polymorphism and sequencing analysis, 1996; http://www.bite-it.helsinki.fi). However, to date we identified three novel AXIN2 gene variants: only a limited number of mutations of MSX1 and PAX9 c.956+16A>G, c.1060-17C>T and c.2062C>T.
    [Show full text]
  • Immunolocalization of Axin2 and P-Smad3 in Developing Rat Molar Germ
    Mitsuko Moriguchi et al.: Axin2 and p-Smad3 in Molar Germ Journal of Hard Tissue Biology 21[2] (2012) p113 - 120 © 2012 The Hard Tissue Biology Network Association Printed in Japan, All rights reserved. CODEN-JHTBFF, ISSN 1341-7649 Original Immunolocalization of Axin2 and p-Smad3 in Developing Rat Molar Germ Mitsuko Moriguchi1), Marie Yamada2), Yasuo Miake1) and Mayu Koshika1) 1) Department of Ultrastructural Science, Tokyo Dental College, Chiba, Japan 2) Department of Physical Therapy, School of Health Science, Niigata University of Health and Welfare, Niigata, Japan (Accepted for publication, February15, 2012) Abstract: Wnt is involved in odontoblast and ameloblast differentiation and matrix protein expression in dentin and enamel, but there have been only a few reports on Axin2 in the Wnt signaling pathway. Axin2 promotes Smad3 activation in the transforming growth factor beta (TGF-ß) signaling pathway, and the presence of cross- talk between the Wnt and TGF-ß signaling pathways has been reported, but there have been no reports on that in odontogenic cells. Thus, we examined immunohistochemically the factors in the 2 signaling pathways using serial sections of rat first molar germ at embryonic day 19 and 10 days after birth to investigate whether there is cross-talk between the 2 signaling pathways through Axin2 and Smad3. Factors in the Wnt signaling pathway: Wnt10, Dishevelled (Dvl), and Axin2, and those in the TGF-ß signaling pathway: TGF-ß receptor 1 (TGF-ß- R1), Smad3, and its active type, phosphorylated Smad3 (p-Smad3), showed similar immunoreactions; in detail, odontoblasts possessing secretory function, rather than dental papilla cells and preodontoblasts, and secretory- stage ameloblasts, rather than inner enamel epithelium, showed stronger reactions, whereas the reaction of maturation-stage ameloblasts was very weak.
    [Show full text]
  • Targeting Wnt-Driven Cancer Through the Inhibition of Porcupine by LGK974
    Targeting Wnt-driven cancer through the inhibition of Porcupine by LGK974 Jun Liua,1, Shifeng Pana, Mindy H. Hsieha, Nicholas Nga, Fangxian Suna, Tao Wangb, Shailaja Kasibhatlaa, Alwin G. Schullerc, Allen G. Lia, Dai Chenga, Jie Lia, Celin Tompkinsa, AnneMarie Pferdekampera, Auzon Steffya, Jane Chengc, Colleen Kowalc, Van Phunga, Guirong Guoa, Yan Wanga, Martin P. Grahamd, Shannon Flynnd, J. Chad Brennerd, Chun Lia, M. Cristina Villarroele, Peter G. Schultza,2,XuWua,3, Peter McNamaraa, William R. Sellersc, Lilli Petruzzellie, Anthony L. Borale, H. Martin Seidela, Margaret E. McLaughline, Jianwei Chea, Thomas E. Careyd, Gary Vanassee, and Jennifer L. Harrisa,1 aGenomics Institute of Novartis Research Foundation, San Diego, CA 92121; bPreclinical Safety, Novartis Institutes for Biomedical Research, Emeryville, CA 94608; cOncology Research and eOncology Translational Medicine, Novartis Institutes for Biomedical Research, Cambridge, MA 02139; and dDepartment of Otolaryngology – Head and Neck Surgery, University of Michigan, Ann Arbor, MI 48109 Edited by Marc de la Roche, MRC Laboratory of Molecular Biology, Cambridge, United Kingdom, and accepted by the Editorial Board October 31, 2013 (received for review July 31, 2013) Wnt signaling is one of the key oncogenic pathways in multiple Cytoplasmic and nuclear β-catenin have also been correlated with cancers, and targeting this pathway is an attractive therapeutic triple-negative and basal-like breast cancer subtypes (9, 10), and approach. However, therapeutic success has been limited because Wnt signaling has also been implicated in cancer-initiating cells in of the lack of therapeutic agents for targets in the Wnt pathway multiple cancer types (11–14). Wnt pathway signaling activity is and the lack of a defined patient population that would be dependent on Wnt ligand.
    [Show full text]